Intermediate and advanced lymphoma may increase the difficulty of treatment, in addition, peripheral T-cell lymphoma and plasmoblastic lymphoma among non-Hodgkin’s lymphoma are relatively difficult to treat.
Lymphoma treatment difficulty is related to clinical stage, intermediate and advanced lymphomas often have multiple lymph node regions involved, diffuse invasion of organs outside the lymph nodes, and poor prognosis, which may cause a decrease in therapeutic efficacy and increased treatment difficulty.
In addition, the difficulty of treatment is also related to the type of pathology, Hodgkin’s lymphoma has a relatively good prognosis, non-Hodgkin’s lymphoma peripheral T-cell lymphoma and plasmoblastic lymphoma are more difficult to treat, with a relatively high recurrence rate after treatment, and the vast majority of them are predominantly in the middle-aged and old-aged, and it is difficult to carry out allogeneic hematopoietic stem cell transplantation, and the prognosis is very poor.
If lymphoma exists, it is recommended to consult the doctor in time for clear diagnosis and active treatment.